The suprachiasmatic nucleus (SCN) defines 24 h of time via a transcriptional/posttranslational feedback loop in which transactivation of Per (period) and Cry (cryptochrome) genes by BMAL1-CLOCK complexes is suppressed by PER-CRY complexes. The molecular/structural basis of how circadian protein complexes function is poorly understood. We describe a novel N-ethyl-N-nitrosourea (ENU)-induced mutation, early doors (Edo), in the PER-ARNT-SIM (PAS) domain dimerization region of period 2 (PER2) (I324N) that accelerates the circadian clock of Per2
; Csnk1e
Tau/Tau mice and the SCN. These periods are unprecedented in mice. Thus, Per2
Edo reveals a direct causal link between the molecular structure of the PER2 PAS core and the pace of SCN circadian timekeeping.
mouse mutant | behavior | protein stability | circadian period | genetic interaction C ircadian rhythms, as exemplified by the sleep/wake cycle, are the outward manifestation of a 24-h timing mechanism that coordinates many physiological processes (1) . The principal circadian clock in mammals is the suprachiasmatic nucleus (SCN). At a molecular level, the SCN clockwork consists of interacting positive and negative transcriptional/translational feedback loops (TTFLs) that drive rhythms in the RNA and protein levels of key clock components. Heterodimers of the PER-ARNT-SIM (PAS) domain-containing transcriptional activators CLOCK and BMAL1 drive rhythmic transcription of Per (period) and Cry (cryptochrome) genes by binding to E-box elements. PER proteins associate with CRY, translocating to the nucleus to inhibit their own transcription by interacting with the CLOCK-BMAL1 complex (2, 3) . An additional feedback loop involves the nuclear orphan receptors REV-ERBα (4) and RAR-related orphan receptor A (RORA) (5) that modify the transcription of Bmal1, thereby stabilizing and amplifying the CLOCK-BMAL complex-dependent oscillation. Once suppressed, CLOCK-BMAL complex-mediated transactivation can only reoccur after PER and CRY have been degraded.
The circadian TTFL is therefore sustained by timely synthesis and degradation of PER and CRY proteins. Changes in PER stability in flies (6, 7) and changes in PER or CRY stability in mammals lead to a faster or slower clock (8) . Phosphorylation-dependent licensing of PER proteins for ubiquitination and subsequent proteasomal degradation is a sensitive checkpoint in setting clock speed (9) (10) (11) . Moreover, two familial advanced sleep phase syndromes (FASPSs) are associated with site-specific phosphorylation of human period 2 (PER2) (12, 13) . Finally, the Tau mutation of casein kinase 1e (Csnk1e) (14) is a hypermorph that accelerates the clock of rodents (15) . Thus, phosphorylation, PER protein stability, and circadian period are intimately linked (16) .
Current knowledge of the structural basis of circadian transcription and its repression is limited, but it is becoming clear that modular PAS domains form protein interactions that are important for progression of the circadian TTFL. The crystal structures of mouse CLOCK and BMAL1 have revealed how tandem PAS domains contribute to the formation of the dimeric transcription factor (17) . PAS domains are also found in circadian negative regulators: tandem PAS domains mediate formation of PER dimers observed in vivo (18) . Unlike the asymmetrical, extended conformation seen in CLOCK-BMAL1, the PER PAS dimer core forms a more symmetrical and compact fold (19, 20) . In PER2, the PAS domain core is followed immediately by a CK1e-dependent phosphodegron that recruits the E3 ubiquitin ligase β-TrCP to control PER2 stability (10, 16, 21) . Thus, control of PER2 repressive function and/or PER2 stability may be controlled by interactions of its PAS domain core.
Significance
In a study investigating mechanisms whereby period 2 (PER2) stability can set the pace of biological rhythms, we have looked at molecular, cellular, and structural features of the mouse mutant, early doors (Edo). Early doors is a novel N-ethyl-N-nitrosourea (ENU)-induced point mutation that shortens the circadian period of mice by 1.5 h. The mutation results in an amino acid substitution in the interdomain linker between the tandem PAS domains of PER2. Biophysical analyses confirm that increased flexibility of this interdomain linker reduces stability of the PAS domain core. This flexibility can accelerate circadian rhythms by destabilizing the PER2 Edo protein through faster kinase-mediated degradation. Furthermore, we find that Per2
Edo mice carrying the casein kinase 1e (Csnk1e) Tau mutation have extremely fast but very stable circadian clocks.
To gain new insight into the mechanisms that determine the pace of the mammalian circadian clock, we used N-ethyl-N-nitrosourea (ENU) mutagenesis (22) . We identified a founder mouse with a significantly shortened circadian period. The mutation, early doors (Edo), mapped to the Per2 gene within the linker between the PAS-A and PAS-B domains. PER2
Edo reveals the determinative relationship between protein stability and circadian pacemaking, and, more importantly, it reveals a structural framework within which to understand this defining property of the circadian system.
Results

Per2
Edo Shortens Circadian Wheel-Running Period. We screened for genetic factors affecting overt behavioral circadian rhythms by monitoring daily wheel-running activity in progeny of ENU mutagenized mice. Within G1/dominant inheritance screens, we identified a mouse with a significantly shortened circadian period (τDD) (Fig. 1A) . Test mating confirmed semidominant heritability of the phenotype, with the following mean circadian periods recorded in outcross/intercross offspring: WT τDD of ∼23.6 h, heterozygote τDD of ∼23 h, and homozygote τDD of ∼22 h ( Fig.  1 B and C) . Homozygotes also displayed a clear advanced phase of entrainment, with activity onsets preceding the onset of the dark phase by several hours. This mutant line was named early doors (Edo; Mouse Genome Informatics accession ID MGI:3606316).
The mutation was mapped by genetic linkage analysis to a 76.5-Mb region of mouse chromosome 1 (Fig. 1D ). Within this region lies the period homolog 2 (Per2). With an established role in the circadian oscillator, this gene was selected as a candidate, and the coding regions of Per2 were resequenced in a mutant animal. Sequencing revealed a T-to-A transversion in exon 9 of the gene (Fig.  1E ). This nonsynonymous missense mutation results in an Ile-toAsn substitution at residue 324 (I324N) of PER2, which lies in the interdomain linker between two tandem PAS domains (Fig. 1F) . The residue is highly conserved within the protein sequence of all mouse Per genes and in the orthologous genes of other vertebrates.
Edo Is a Gain-of-Function Allele. Several null alleles of mPer2 have been described, and have been shown to have either no effect on circadian period (23) or to disrupt rhythms (24, 25) . To define the genetic status of the Per2
Edo allele, we created compound heterozygous mice alongside single mutants and controls and then monitored wheel-running behavior. The Per2 genotype had an overall significant effect on the period of behavioral rhythms (1× ANOVA F = 22.4; 3,20 df; P < 0.001; Fig. 2A ). Whereas Per2
Edo/Edo mice exhibited accelerated period compared with WT (period: Per2 +/+ = 23.9 ± 0.1 h, Per2
Edo/Edo = 22.4 ± 0.2 h; n = 3, 6; P < 0.01), Per2 −/− mice had periods (24.0 ± 0.2 h; n = 6) not significantly different from WT and significantly (P < 0.01) longer than Per2
Edo/Edo . Moreover, the period of Per2
Edo/− compound heterozygotes (23.5 ± 0.1 h; n = 9) was intermediate between Per2
Edo/Edo and Per2 −/− mutants, although still significantly (P < 0.01) longer than the period of Per2
Edo/Edo
. At a behavioral level, therefore, Per2
Edo is not a loss-of-function mutation. To explore the dose dependence of this effect, SCN slices were prepared from Per1-Luc reporter mice, heterozygous or homozygous for Per2
Edo
. As with behavior, heterozygous mice showed a period acceleration of 0.56 h, and a second copy of Per2
Edo accelerated the clock further, to 1.23 h shorter than WT (1× ANOVA F = 5.0; 2,36 df; P < 0.02; Per2
Edo/Edo : t = 3.1, P < 0.05; Fig. 2B ). There was no effect of Per2
Edo genotype on the amplitude of oscillation reported by Per1-luc. We then examined SCN function in compound heterozygotes and controls using the Per1-luc reporter (Fig. 2C) . As with behavioral rhythms, Per2 genotype had an overall effect on circadian period (1× ANOVA F = 39.4; 2,55 df; P < 0.001). The SCN of Per2 −/− mice had a period comparable to WT SCN (period: Per2 +/+ = 23.9 ± 0.1 h, Per2 −/− = 23.8 ± 0.1 h; n = 9). In contrast, but consistent with behavioral findings, Per2
Edo dose-dependently accelerated the SCN clock. : t = 7.5, P < 0.001). Thus, data from SCN ex vivo studies support the behavioral observations that Per2
Edo is a gain-of-function, probably antimorphic, mutation.
We tested whether the accelerated Per2 Edo SCN affected peripheral clocks. The liver of Per2
Edo/Edo mice held on a 24-h light/ dark (L/D) schedule exhibited very robust daily cycles of gene expression, with amplitudes comparable to the amplitudes of liver from WT mice (Fig. S1 ). There was a marked advance of ca. 3 h in the phase of the peripheral oscillations for both core clock genes (Bmal1, Per1, Per2, and Cry1) and the canonical circadian output gene Dbp. This phase advance is likely a consequence of the advanced phase of the behavioral rhythm exhibited in the homozygous mutants when entrained to the L/D cycle (Fig. 1A) . Thus, the shortened period of the Per2 Edo/Edo SCN, and perhaps also an accompanying acceleration of the local liver clock, had a significant effect on peripheral circadian organization.
Finally, to confirm that Per2 Edo is not a null allele, serial sections of SCN were immunostained with anti-PER2 serum (26) . In WT SCN collected at the peak of PER2 expression (Zeitgeber time 12, lights-off), nuclear immunolabeling was extensive across the SCN (Fig. 2D) . In homozygous PER2-null SCN, immunolabeling was absent. In contrast, SCN from Per2
Edo/Edo mice exhibited widespread nuclear immunoreactivity, comparable to the nuclear immunoreactivity of WT (cell counts: Per2 +/+ = 413 ± 26; Per2 Edo/Edo = 256 ± 53; Per2 −/− = 2 ± 1; n = 3 per group; 1× ANOVA F = 36.3; 2,6 df; P < 0.001; Per2 +/+ vs. Per2
Edo/Edo : t = 3.2 ns; Per2 +/+ vs. Per2
Edo thus encodes a PER2 variant highly expressed and trafficked appropriately to the nucleus of SCN neurons. To characterize the biochemical properties of PER2 Edo likely to underpin the accelerated clock, we initially focused on protein dimerization, a function determined by the PAS domains where the mutation is located. PER2 PAS domains mediate the formation of homodimers and heterodimers with both PER1 and PER3 (19, 20) . Using site-directed mutagenesis, we created the I324N mutation in full-length PER2 and expressed proteins in COS7 cells with various C-terminal tags. Immunoblotting of cell lysates confirmed the appropriate expression of all tagged proteins ( Fig. S2 A-C) . Coimmunoprecipitation showed that PER2
Edo exhibited the expected homodimerization and associations with CRY2, whereas minimal interactions were found with REV-ERBα and BMAL1. Importantly, PER2
Edo exhibited comparable associations that, within the limits of the assay, were not significantly different from the associations of PER2 WT (Fig. S2D ). Given that association with CRY is thought to direct nuclear translocation of PER, we expressed tagged PER2 and CRY1 and monitored their cellular localization. In the absence of CRY1, both PER2 variants were predominantly cytoplasmic ( Fig. 2E) . Cotransfection with CRY1, however, localized both variants to the nucleus. Thus, the mutation did not compromise functional interaction between PER2 and CRY1, and it did not appear to affect the subcellular localization of either.
Steady-state analyses of the intracellular behavior of PER2 Edo failed to reveal significant effects of the mutation. Given that nuclear localization and complex formation can influence the degradation of circadian proteins, we monitored the real-time decay of bioluminescent PER2::LUC fusion proteins in HEK293 cells to test the relative vulnerability of PER2 Edo to proteasomal degradation triggered by CK1e (15) . Following treatment with the translational inhibitor cycloheximide, bioluminescent signal for cytoplasmic PER2::LUC declined progressively in the presence of CK1e. Degradation of EDO::LUC, however, was more rapid (Fig. 2 F and I). The t 1/2 of EDO::LUC was slightly but significantly shorter (36 min) than PER2::LUC (P = 0.0223, t test). In the presence of CRY, the vulnerability of nuclear EDO::LUC to CK1e-mediated degradation was even more pronounced (151 min shorter; P = 0.0005, t test; Fig. 2 G and I). Although the t 1/2 of nuclear PER2::LUC was substantially longer in this study, the EDO::LUC t 1/2 was shorter. Finally, coexpression with CK1e
Tau in the presence of CRY resulted in a consistent shorter t 1/2 in EDO::LUC (23 min; P = 0.0035, t test; Fig. 2 H and I). Thus, although the Edo mutation did not prevent PER2
Edo from forming complexes with other circadian proteins, the vulnerability of PER2
Edo to CK1e-mediated degradation was nevertheless greater.
PER2
Edo Increases Flexibility of Interdomain Linker to Destabilize the PAS Domain Core of PER2. The Edo mutation is located in a conserved linker between the two PAS domains that is distant from the dimer interface observed in the crystal structure (19) , consistent with our finding that Edo does not have an impact on dimerization in full-length proteins or in the purified tandem PAS domains [PAS-A and PAS-B (PAS-AB) domains; Fig. S3 A and B]. However, we reasoned that substitution of the more polar Asn at this site might disrupt packing of the linker to influence conformation of the PER2 Edo PAS-AB dimer in solution. This possibility was assessed using small-angle X-ray scattering (SAXS), which provides lowresolution envelopes of protein structures in solution (27) . Scattering curves for PER2
WT and PER2 Edo were essentially identical and confirmed dimer formation ( exhibiting a decrease in melting temperature (T m ) of more than 5°C (Fig. 3C) , which corresponds to a change in the free energy of unfolding, ΔΔG, of 0.66 kcal/mol at the WT T m of 54.6°C. Therefore, Edo decreases the intrinsic stability of the PER2 PAS domain core without causing global changes in the overall structure.
To determine how Edo influences stability of the PAS domain core, we probed flexibility of the protein backbone using limited proteolysis. Digestion with chymotrypsin showed no difference between PER2
WT and PER2 Edo (Fig. S3H ), but we observed a pattern of differential cleavage by trypsin (Fig. 3D ): first, a short peptide was preferentially cleaved from the C terminus of PER2 WT ; second, PER2
Edo preferentially accumulates ∼21-kDa fragments ( Fig. S3 I and J) . Specific cleavage sites were identified by liquid chromatography/MS. Cleavage at K451 in the linker to the Jα helix occurred preferentially in PER2 WT , whereas cleavage of the interdomain linker at R323 and R329 occurred preferentially in PER2 Edo (Fig. 3E) . The interdomain and Jα linkers interact with one another and the PAS-B domain through hydrophobic packing and electrostatic interactions, including a salt bridge between R323 and E439 (Fig. 3F ). This network of interactions suggests how Edo could influence the flexibility of two linkers that are separated by the PAS-B domain in the primary sequence (Fig. S3K) .
The phosphodegron that regulates CK1e-dependent turnover of PER2 is located immediately downstream of the Jα helix (Fig.  3 E and G) . The structure ends at P473 and is followed by the sequence HSGSSGYGS (residues 474-482), where phosphorylation by CK1e at the underlined Ser residues facilitates binding of the E3 ubiquitin ligase β-TRCP1 (10, 16, 21) . Therefore, alterations to the stability and flexibility of the PAS-AB domains may further contribute to destabilization of the mutant in vivo by altering accessibility of this motif. In support of this argument, we found a stronger interaction between β-TRCP1 and PER2 Edo when coimmunoprecipitated from HEK293 cell protein complexes (P = 0.022, t test; Fig. 3 H and I ).
Edo Is More Sensitive to CK1e-Mediated Degradation in Vivo, Generating an Extremely Rapid Circadian Clock. To test predictions based on our biochemical and biophysical analyses in vivo, we crossed the Per2 Edo mutation with the Csnk1e Tau mutation. Our prediction was that availability of the more vulnerable PER2 Edo substrate would allow the mutant CK1e to accelerate the circadian TTFL even further than in a Per2 +/+ background. As anticipated, Csnk1e
Tau/Tau mice were unable to entrain to the 24-h lighting cycle regardless of whether they carried the additional Per2
Edo/Edo allele ( Fig. 4 A and B) , whereas mice carrying Per2
Edo/Edo alone could still entrain. Under continuous dim red light, the free-running periods revealed an additive effect of the two mutations. Both alleles contributed to a shortening of the behavioral circadian period, as revealed by significant main effects of Csnk1e
Tau and Per2 Edo by two-way ANOVA (P < 0.0001 for both). There was not, however, any interaction (P = 0.35). For each of the three Csnk1e
Tau genotypes tested, the periods of Per2
Edo/Edo mice were significantly shorter than the periods of Per2 +/+ controls. Notably, the period of the double-homozygous animals was 18.80 ± 0.04 h, which is an unprecedentedly fast behavioral rhythm in mice, and comparable to the ultrashort period of "super-duper" hamsters (28) .
To confirm that these additive genotypic effects occurred within the SCN, slices were made and the circadian period was determined by recording Per1-luc bioluminescence (Fig. 4C) . As with behavior, both alleles contributed to a shortening of the circadian period (main effects two-way ANOVA: P < 0.0001 for both). Again, there was no interaction (P = 0.18), confirming their additive, independent actions. Thus, for all three Csnk1e Tau genotypes tested, the periods of Per2
Edo/Edo SCN were significantly shorter than the periods of Per2 +/+ controls, creating, again, an unprecedentedly short, genetically specified circadian period for the SCN of 18.80 ± 0.06 h.
Discussion
Edo is a novel ENU-induced mutation that shortens the circadian wheel-running period in mice, an effect mediated by accelerated molecular pacemaking in the SCN. The point mutation in Edo lies in the interdomain linker (I324N) between two PAS domains in PER2, and has the effect of increasing linker mobility and reducing stability of the core PAS dimer in PER2 Edo in vitro. This mutation is associated with increased vulnerability of PER2
Edo to CK1e-dependent degradation in vivo. Thus, in Per2 Edo ; Csnk1e Tau mice, the combination of increased vulnerability of the substrate with the gain-of-function enzyme leads to extremely short circadian periods of behavior and SCN gene expression.
By uncovering a new allelic variant of Per2, the current study illustrates the continuing value of forward genetic screens to understand circadian mechanisms. The accelerated oscillation in the Edo SCN emphasizes the critical role of protein stability in setting the circadian period. The interaction between PER2 and CK1e is clearly pace-setting, as revealed by accelerated clocks in mutants of CK1e and CK1δ in rodents and humans, respectively, and in the human PER2 FASPS mutant (12) now alongside mouse PER2 Edo . These observations are consistent with the view that the rhythmic availability of PER2 "defines a critical nodal point for negative feedback" within the TTFL (29) . Moreover, the Edo mutation accelerates/phase-advances mRNA rhythms in the liver that are, again, as well defined as the mRNA rhythms seen in WT animals. Thus, a genetic background that accelerates PER2 degradation generates an ultrashort <19-h circadian period in the SCN and in activity/rest cycles. In hamsters, a comparably fast period is seen in compound mutants for Csnk1e
Tau and "duper," an unidentified mutation that does not reside in hamster Per2 (28) . Critically, the rhythms in hamsters and mice alike are as robust and coherent as in the 24-h WT, highlighting the precision and stability of the SCN oscillator remaining unperturbed in the face of a >20% acceleration of the TTFL.
Importantly, Edo does not phenocopy the Per2 null mutant. First, by immunostaining and circadian recording, it is clear that PER2 Edo is expressed and functional. Second, it displays semidominant inheritance, with progressively severe heterozygous and homozygous phenotypes. This phenotype is a notable variation from targeted deletions of Per2, which are phenotypically recessive. Third, this phenotype is expressed in the compound heterozygote Per2 Edo/− . It therefore acts as a gain-of-function mutation. We speculate that this gain of function is due to maintenance of normal interactions of PER2 Edo with other clock proteins (e.g., CRY), whereas its more rapid turnover leads to a change in the repressive "nodal set point" established by PER2 (29) .
Having characterized the phenotypic consequences of the mutation in vivo, we explored its biochemical and structural features to discover that Edo destabilizes the PAS domain dimer core to accelerate PER2 degradation. Notably, Edo does not induce global changes in dimer structure as assessed by size-exclusion chromatography and SAXS. Here, we show that Edo alters the flexibility of linkers in the PAS domain core to elicit its dramatic overall effect on PER2 function. Edo makes the PAS domain core less intrinsically stable and also leads to increased interaction with its E3 ubiquitin ligase β-TRCP1, leading to increased turnover in vivo. Given the modest buried surface area between the interdomain linker and the PAS domains (590 Å 2 ), it is perhaps surprising that substitution of one residue has such profound implications for PER2 structure and function. However, the interdomain and Jα linkers are linked through a series of interactions on the PAS-B domain, potentially connecting the Edo site to the CK1e-dependent phosphodegron immediately downstream of the Jα helix (16) . The biochemical basis of the interaction between PER2 and CK1e is, however, unclear. A current model posits that the Tau mutation changes the relative efficacy of CK1e at two competing phosphorylation sites that determine whether PER2 has a fast or slow degradation rate (16) . Further work will be necessary to understand the structural basis by which linker flexibility enhances interaction with CK1e-dependent β-TRCP1 activity to control PER2 stability in vivo. Our data reaffirm the central role of PAS-mediated mechanisms in tuning the period of the mammalian circadian clock, and thereby extend the scope of molecular structure-based analysis of cellular timekeeping. (15)]. All molecular and behavioral studies were carried out in mice bred on a congenic C57BL/6J background.
Methods
Mutagenesis, Genetic Mapping, and Mutation Detection. Mutagenesis, screening, genetic linkage, positional candidate analysis, and sequencing were carried out as described previously (22, 33) .
SCN Slices. SCN organotypic slices for bioluminescence recordings and immunostaining of SCN PER2 expression were as described previously (26) .
Cell Culture and Transfection. COS7 and HEK293 cells were maintained in DMEM supplemented with 10% (vol/vol) FBS and antibiotics (100 μg/mL penicillin and streptomycin). (gray bars) mice in the presence or absence of Csnk1e Tau mutant alleles (mean ± SEM; ***P < 0.001, **P < 0.01, *P < 0.05 by t test).
Francisco, CA) or EDO::LUC generated by site-directed mutagenesis (Stratagene). Reporter constructs were cotransfected with combinations of CK1e WT , CK1e
Tau , and mCry2-HA plasmids. Bioluminescence degradation studies were conducted as in the study by Hirano et al. (34) . Luciferase activity of PER-LUC was recorded at 10-min intervals at 37°C with Lumicycle (Actimetrics). The data were fitted to an exponential curve of the form N(t) = N 0 e (−λt) where N(t) is the luminescence (counts per second) at time t, N 0 is the initial luminescence (counts per second), λ is the decay rate, and t is the time. The rate of λ was determined using a MATLAB (MathWorks) Curve Fitting Toolbox, and t 1/2 was calculated using the t 1/2 equation t 1/2 = ln (2)/λ.
For coimmunoprecipitation experiments, cells were transfected with mPER2 WT -V5-YFP-His, mPER2
Edo -V5-YFP-His, or β-TRCP1-V5-His plasmids and mCry2-HA, HA-mPER2, HA-mPER2 Edo , mBmal1-FLAG, mRev-erba-V5, respectively, in 10-cm dishes in medium without antibiotics. The total amount of transfected DNA was 6 μg (composed of 3 μg of mPer2 WT or mPer2 mutant and 3 μg of mCry2-HA, HA-mPer2, HA-mEdo, HA-mPer1, mBmal1-FLAG, mClock-HA, mRev-erba-V5). Forty-eight hours after transfection, cells were washed three times with cold PBS, lysed in 700 μL of lysis buffer, and treated as described above.
Coimmunoprecipitation and Western Blotting. Tagged proteins were immunoprecipitated from COS7 or HEK293 cell lysates with anti-V5 (R960-25; Invitrogen), anti-HA (HA.11; Covance), or anti-FLAG M2 (F3165; Sigma) following 2 h of gentle agitation at 4°C with 25 μL of protein G agarose. Samples were washed in buffer, boiled at 95°C for 5 min, separated by SDS/PAGE on a 4-12% gel, and transferred to a PVDF membrane. Immunoblotting was performed using anti-V5 (1:3,000), anti-HA (1:1,000), anti-FLAG (1:800), and anti-GFP (1:5,000) (11814460001; Roche). Secondary Ab was HRP-conjugated anti-mouse (Sigma) at a 1:10,000 dilution. Chemiluminescence was performed using ECL Plus (Amersham).
Recombinant Protein Expression and Purification. A fragment containing the tandem mouse PER2 PAS-AB domains (residues 170-473) was expressed in Escherichia coli as a fusion with a tobacco etch virus (TEV)-cleavable N-terminal His 6 tag. The Edo mutation (I324N) was introduced by site-directed mutagenesis and validated by sequencing. Protein expression was induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside at an OD 600 of ∼0.8, and E. coli was grown for an additional 16 h at 18°C. Soluble proteins were purified by Ni 2+ -nitrilotriacetic acid affinity chromatography (QIAGEN), followed by cleavage of the His 6 tag with TEV protease for either 4 h at room temperature or overnight at 4°C. Subsequent Ni 2+ -nitrilotriacetic acid affinity chromatography was performed to remove the protease and cleaved tag. Proteins were further purified by sizeexclusion chromatography on a Superdex 75 16/60 prep grade column (GE Healthcare) equilibrated in 25 mM Hepes (pH 7.5), 200 mM NaCl, and 5 mM DTT, and then concentrated to 10 mg/mL. Concentration of the purified, cleaved proteins (residues 170-473 with an N-terminal "GAMDP" remaining after TEV cleavage) was determined at A 280 using a calculated extinction coefficient of 32,890 M 
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Militi et al. 10 .1073/pnas.1517549113 SI Methods ENU Mutagenesis and Wheel-Running Activity Screen. Briefly, male BALB/c mice were injected i.p. with two weekly injections of 100 mg/kg ENU (Sigma) at ∼10 wk of age (35) . After a period of temporary sterility (about 15 wk), they were crossed to C3H females, and the F1 progeny were screened for abnormal circadian behavior from 6 to 12 wk of age. To test inheritance of an abnormal phenotype, F1 founder mice were backcrossed to C3H mice and the backcross progeny were assessed for the inheritance of the abnormal phenotype. Mutant mouse lines were also transferred onto a C55BL/6J background once they could be genotyped. Screens were carried out by transferring the mice to individual cages equipped with running wheels and maintained within light-tight ventilated chambers with timer-controlled lighting. Wheel-running data were collected and analyzed using Clocklab (Actimetric Software).
Genotyping. For genotyping Edo mice, ear biopsy DNA was subjected to a PCR discrimination assay, with amplification of exon 9 and the flanking region of Per2 by the primers 5′ TTGAGTAT-TTCCCTAGTTATTGCAG 3′ and GCGACACGGAGGACACAG, followed by HinfI digest. Agarose gel electrophoresis revealed bands of 241 bp (WT), 241 bp, 144 bp, and 97 bp (heterozygote) and of 144 bp and 97 bp (homozygote). Genotyping for other lines was as described (24, 26, 31, 32) .
RNA Extraction, RT, and Real-Time PCR. Homozygous Edo mutants and littermate controls on a 12-h/12-h L/D cycle were killed at 4-h intervals by cervical dislocation, and livers were harvested, dissected, immediately snap-frozen on dry ice, and stored at −80°C. RNA was extracted using the standard TRIzol extraction protocol (Life Technologies). The total RNA concentration was determined using a nanodrop ND-1000 (Thermo Fisher Scientific). mRNA expression was determined using SYBR Green RT-PCR assays utilizing the following primers: The RT reactions were conducted using a SuperScript III FirstStrand Synthesis for qRT-PCR kit with 1 μg of RNA (protocol for part 11752-050; Life Technologies). The RT-PCR reactions were performed in triplicate using 10 μL of 2× Power SYBR Green PCR Master Mix (Life Technologies), 2 μL of product from the RT reaction (diluted 1:4), 1 μL of 2 μM primer mix (containing both the forward and reverse primers), and 7 μL of nuclease-free water. A sample minus RT buffer was used as a negative control for the RT-PCR reactions. None of the negative controls reached threshold by 45 cycles. RT-PCR reactions were run on a 7500 Fast Real-Time PCR System (Applied Biosystems) in 96-well format. Relative expression was calculated using the standard 2
cycle threshold relative expression method in Microsoft Excel. The relative expression of the individual samples was normalized to the Rlpl3a.
Plasmids. Plasmids for Per2-HA, Bmal1-Flag, and CK1e were a gift from Filippo Tamanini (Erasmus University Medical Center, Rotterdam, The Netherlands). V5-YFP-His epitope-tagged mPer2 and mCry2-HA were generated in-house. To create the mREV-ERBA-V5-His expression vector, Rev-erba cDNA was PCRamplified using primer pairs 5′-CAACATGACGACCCTGGAC-TCC-3′ and 5′-CTGGGCGTCCACCGGGAA-3′ and cloned into a pENTR/D-TOPO vector using a pENTR Directional TOPO Cloning Kit (K2400; Invitrogen) to produce an entry clone. The latter, containing an Rev-erba gene, was then introduced into the pcDNA-DEST40 expression vector by following the Gateway Technology with Clonase II (12535-029; Invitrogen). Similarly, the bTRCP1-V5-His expression vector was created by amplifying βTrcp1 cDNA from primer pairs 5′-CACCATGGACCCGGCA-GAGGCGGTG-3′ and 5′-TCTGGAGATGTAGGTGTATGT-3′ and subcloned as above. The sequences of pENTR/D-TOPO and pcDNA-DEST40 vectors are available for downloading from the Invitrogen web site (www.thermofisher.com).
Site-Directed Mutagenesis. Amino acid substitution in the mPER2 PAS-B domain of mPER2 (full)-V5-YFP-His and HA-mPER2 (full) was generated using a QuikChange XL Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer's directions. Mutagenesis primers for the Edo mutant were 5′-CTCAGGAG-GGTTTCTAGGCGCTTCATAGCC-3′ and its complementary strand. The presence of the expected base pair substitution was confirmed by DNA sequencing.
Size-Exclusion Chromatography. For estimation of dimerization state by size-exclusion chromatography, purified proteins were injected on a Superdex 75 10/300 GL analytical column at 160 μM (∼6.4 mg/mL) in 25 mM Hepes (pH 7.5), 200 mM NaCl, and 5 mM DTT. All sizeexclusion columns were calibrated with a low-molecular-weight gel filtration standards kit (GE Healthcare Life Sciences).
SAXS. SAXS data were collected on the SIBYLS beamline (12.3.1) at the Advanced Light Source (Lawrence Berkeley National Laboratory). Multiple exposures of three concentrations (1, 3, and 5 mg/mL) of freshly purified protein were taken to check for concentration dependence of scattering and radiation damage (neither was detected). After buffer subtraction, experimental scattering curves were compared with a theoretical scattering curve derived from the X-ray crystal structure (Protein Data Bank ID code 3GDI) using FoXS (36) , giving a χ fit of 16.0. To improve on the fit, AllosMod FoXS was used to build in the missing loops from the crystal structure, improving the χ fit to 2.70. Scattering data were further analyzed using the ATSAS suite of programs (37) . Briefly, data were merged using PRIMUS, and the radius of gyration was determined using the Guinier approximation. The pairdistance distribution function [P(r)] and maximal particle size (D max ) were generated in GNOM, and the output data were used by GASBOR to calculate 10 independent solution envelopes that were averaged together using DAMAVER. The improved model of the solution structure was used in UCSF Chimera (38) to fit into the averaged solution envelope. Scattering datasets, analysis, and models have been deposited with BioISIS (www.bioisis.net) with the following deposition codes: PLCSWP (PER2 WT ) and PLCSEP (PER2 Edo ).
Limited Proteolysis. Limited proteolysis of purified proteins was performed at 1.5 mg/mL in 25 mM Hepes (pH 7.5), 200 mM NaCl, and 5 mM DTT with sequencing-grade proteases (Promega) for 1 h at room temperature with the following mass (wt/wt) ratios: chymotrypsin (1:25, 1:50, and 1:100) or trypsin (1:100, 1:250, and 1:500). To visualize proteins by Coomassie staining, reactions were quenched with addition of an equal volume of 2× SDS Laemmli buffer (Bio-Rad) and samples were boiled at 95°C for 5 min. Digested fragments were resolved by 18% SDS/ PAGE and visualized by Coomassie staining. For immunoblotting, the same gel samples were first diluted 50-fold in 1× SDS Laemmli buffer and then separated by 18% SDS/PAGE and transferred to a nitrocellulose membrane. Immunoblotting was performed using anti-His 6 1:2,000 (AM1010a; Abgent). Secondary Ab was HRP-conjugated anti-mouse (A9917; Sigma) at a 1:10,000 dilution, spiked with a 1:10,000 dilution of anti-Streptactin-HRP (161-0380; Bio-Rad) for direct visualization of Western C protein markers (Bio-Rad). Chemiluminescence was detected with Clarity reagent (Bio-Rad) and detected via a CCD camera on a ChemiDoc gel imaging system (Bio-Rad).
Proteolytic samples for MS were quenched by addition of formic acid to a final concentration of 1% (vol/vol). Samples were desalted and separated by HPLC (Surveyor; Thermo Finnegan) on a Proto 300 C4 reverse-phase column with a 100-mm × 2.1-mm inner diameter and 5-μm particle size (Higgins Analytical, Inc.) using a mobile phase consisting of solvent A (0.1% formic acid in HPLC grade water) and solvent B (0.1% formic acid in acetonitrile). The samples were analyzed on an LTQ Orbitrap linear ion trap mass spectrometer system (Thermo Finnegan). Proteins were detected by full-scan MS mode (over an m/z of 300-2,000) in positive mode with the electrospray voltage set to 5 kV. Mass measurements of deconvoluted electrospray ionization mass spectra of the reversed-phase peaks were generated by Magtran software. Observed masses were within 0.01% error of calculated masses after accounting for cleavage of the N-terminal methionine (loss of 131 Da), a common occurrence for proteins expressed recombinantly in E. coli (39) .
Differential Scanning Fluorimetry. Stability of purified proteins was assessed by miniaturized differential scanning fluorimetry using SYPRO Orange dye (Sigma-Aldrich) (40) . Proteins were diluted to 10 μM with 25 mM Hepes (pH 7.5), 200 mM NaCl, 5 mM DTT, and SYPRO Orange dye at a final concentration of twofold. Fifty-microliter aliquots of PER2
WT and PER2 Edo were plated in replicate (n = 6) into a 96-well PCR plate and sealed with optically clear film (Invitrogen). Thermal denaturation was performed in a ViiA7 Real-Time PCR instrument (Applied Biosystems) using changes to the default Melt Curve program as previously described (40) . Raw fluorescence data were processed in Microsoft Excel, and T m s were obtained by nonlinear regression of sigmoidal denaturation curves using GraphPad Prism 6 as previously described (40) . Data shown are representative of three independent assays. The equilibrium constant for unfolding (K U ) was determined after estimating the fraction of protein unfolded (F U ) as a function of temperature using the following equation:
where Fl obs corresponds to the fluorescence observed at a given temperature, Fl native is the baseline fluorescence for natively folded protein, and Fl unfolded corresponds to fluorescence at the upper plateau (determined after subtraction of postpeak fluorescence quenching). K U was determined with the following equation:
and used to calculate the free energy for unfolding of WT and Edo protein at the T m for WT PER2 PAS-AB domain (∼55°C). Table of parameters derived from analysis of SAXS data. D max , maximal particle size (in angstroms); I(0), extrapolated scattering intensity at zero scattering angle q; r, particle radius (in angstroms); R g , radius of gyration; V c , volume of correlation; Vol, volume. (F) Loops missing from the PER2 crystal structure (Protein Data Bank ID code 3GDI) were modeled using AllosMod FoXS (36) to find the top 10 models that best fit the SAXS data. The model shown here represents the best fit to the SAXS data (χ = 2.70). One monomer is shown in surface representation and the other as a cartoon with PAS-A domains (yellow), PAS-B domains (orange), and interdomain linker (gray) with I324 in red. Added loops are depicted on one monomer in teal. Fig. 3F ), and the other is shown in cyan as a cartoon representation. Distances are shown between I324 and (i) the dimer interface at W419 (19) ; (ii) the trypsin cleavage site at K451 in the linker to the Jα helix; and (iii) P473, the last residue of the structure before the CK1e-dependent phosphodegron (16) . Note that the Jα helix and phosphodegron from the cyan monomer are also located in close proximity to the W419 dimerization interface on the left.
